Steven E Nissen. Show Affiliations »
Abstract
Entities: Gene
Mesh: See more » Cardiovascular Diseases/chemically inducedDiabetes Mellitus, Type 2/prevention & controlHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useRosiglitazoneThiazolidinediones/adverse effectsThiazolidinediones/therapeutic use
Substances: See more » Hypoglycemic AgentsThiazolidinedionesRosiglitazone
Year: 2006 PMID: 17161720 DOI: 10.1016/S0140-6736(06)69825-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321